BMAL1 and lung cancer: Genome-wide association studies (GWAS) reveal that variants in BMAL1 are associated with insulin resistance (20, 21), cardiovascular health (21, 22), prostate cancer (23), lung cancer (24), chronotype (25), sociability (26), and neurodegeneration (27).